Malaria is a mosquito-transmitted infectious disease caused by intracellular protozoan parasites of the genus Plasmodium. In the absence of prompt and appropriate treatment contraction of primary infection by a human being often represents a medical emergency since it may progress rapidly to life-threatening complications. Exposure to parasites activates the immune system resulting in, among other effects, the release of reactive oxygen intermediates (ROI). This has the potential to induce oxidative damage, thereby causing cellular destruction, and hence to have a severe effect on vital organs of the body. Overexpression of ROI leads to immunosuppression and is a causal factor in the development of malaria-related disease symptoms. However, the body possesses various defence mechanisms, notably including the production of antioxidants, which are capable of reducing the cellular effects of ROI. Antioxidants are either sourced exogenously from the diet or synthesized through different intracellular mechanisms. Antioxidants that include glutathione peroxidase, catalase, EDTA and vitamin C suppress the initial production of ROI. Others such as uric acid, superoxide dismutase and vitamin E may also inhibit potentially damaging products of ROI metabolism. Current anti-malarial drugs often have damaging side-effects, as exemplified by memory impairment following treatment for cerebral malaria. Recent studies have explored the potential use of antioxidants alone or in combination with anti-malarials as a therapeutic means to negate Plasmodiuminduced oxidative stress and its associated metabolic complications. It is indicated that when utilized in an adjuvant capacity antioxidants of natural and synthetic origin may improve anti-malarial therapy by causing less damage to the host during malaria infection.
Introduction
Malaria is an infectious disease of vertebrates caused by intracellular protozoan parasites belonging to the genus Plasmodium, of which five species are capable of infecting humans (1) . Transmission between hosts occurs via the bite of an infected female Anopheles mosquito (1, 2) . Malaria is at present endemic in 110 countries and is found on every continent, bar Antarctica, but is confined to mainly tropical and subtropical regions (3, 4) . Of the estimated global population of 7.3 billion people, 3.5-3.7 billion are at risk of contracting malaria (3, 5) . In the absence of prompt diagnosis and appropriate treatment disease can escalate to life-threatening complications, such as cerebral and renal manifestations (6) . It is routinely claimed that there are 300-500 million clinical cases worldwide annually (7) . The 1-3 million deaths that result equate to a death every 10-30 seconds (8, 9 ).
90% of deaths are due to P. falciparum and occur principally in young children in sub-Saharan Africa.
P. falciparum Infection Stimulates Host Immunity
The life cycle of P. falciparum includes a symptomless, non-pathogenic liver stage of 7-10 days duration followed by the invasion of aged erythrocytes by infective forms, merozoites, which heralds the start of an intraerythrocytic vegetative growth cycle that is responsible for the pathogenic manifestations of disease (Fig. 1) . Erythrocytes rupture once mature schizonts are produced, which occurs 46-48 hours after invasion.
Every erythrocyte releases between 16-32 merozoite progeny, each of which may bind to and enter a new erythrocyte to initiate a further cycle of asexual replication (4).
The human immune response against malaria infection is complex and depends on different stages of the life cycle (10) (Fig. 1) 
P. falciparum Infection Activates ROI
Malaria infection activates the immune system resulting in the release of reactive oxygen intermediates (ROI) that induce oxidative damage which has the potential to kill parasite-infected hepatocytes and erythrocytes but also to cause cellular pathology (17) . 
Effects of Antioxidants on Malaria
Many protective mechanisms have evolved to reduce the harmful effects of free radicals on cells.
These include antioxidants like glutathione (GSH) and Further research into this concept is required.
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